Utah Approves Pilot Program for Psychedelic-Assisted Therapy
Utah is taking a bold step towards addressing its mental health crisis by allowing doctors at two major healthcare systems to treat patients with psilocybin and MDMA. These drugs, traditionally classified as illegal, are showing promise in treating conditions like depression, anxiety, and PTSD.
Governor Approves Despite Concerns:
While Governor Cox expressed support for exploring new treatment options, he also voiced disappointment that a previously established task force was bypassed. This task force recommended waiting for FDA approval before legalizing these drugs. Unlike a similar bill rejected in 2023, this year’s pilot program focuses solely on therapeutic use and avoids production legalization.
Addressing a Growing Need:
Senator Cullimore, the bill’s sponsor, emphasized the need to address Utah’s high rates of depression and suicide, particularly among young adults. He believes this program empowers doctors to make the best treatment decisions for their patients.
Research Boom Fuels Revival:
Once heavily stigmatized, psilocybin (“magic mushrooms”) and MDMA (“ecstasy”) are undergoing a scientific renaissance due to their potential therapeutic applications. Research, both professional and citizen-driven, has been flourishing within Utah.
Program Details:
- The pilot program is limited to University of Utah Health and Intermountain healthcare systems.
- Treatments will occur in controlled medical settings, with no take-home options like medical cannabis.
- The program sunsets in three years, allowing for legislative evaluation and potential continuation.
- Participating healthcare providers will be required to report data on drug use, side effects, patient outcomes, and other metrics.
Looking Forward:
Implementing this program requires significant planning according to Dr. Ashworth, medical director at Huntsman Mental Health Institute. The University of Utah Health system will review available data and develop an implementation plan once the program officially begins on May 1st.